NCT02063880View on ClinicalTrials.gov

Pediatric Urgent Start of Highly Active Antiretroviral Treatment (HAART)

NACompletedINTERVENTIONAL
Enrollment

183

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Human Immunodeficiency VirusImmune Reconstitution Inflammatory Syndrome
Interventions
OTHER

Urgent ART

Children will be started on HAART \<48 hours after enrollment.

OTHER

Early ART

Children will be started on ART after stabilization 7-14 days after enrollment.

Trial Locations (4)

Unknown

JOOTRH, Kisumu

Kisumu District Hospital, Kisumu

Kenyatta National Hospital, Nairobi

0202

Mbagathi District Hospital, Nairobi

All Listed Sponsors
collaborator

University of Nairobi

OTHER

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

University of Washington

OTHER

NCT02063880 - Pediatric Urgent Start of Highly Active Antiretroviral Treatment (HAART) | Biotech Hunter | Biotech Hunter